𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired cell-mediated immunity in patients with cancer

✍ Scribed by Dr. Joseph A. Buda; N. Suciu-Foca; Eric Blomain; Susan McManus; Keith Reemtsma

Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
289 KB
Volume
7
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impaired cell-mediated immunity of appar
Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancers
✍ D. Czarnecki; J. ZalcberΗ΅; E. KulinskΓ‘ya; T. Kay πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

## Background: Investigations of the immune status of patients with skin cancer have had conflicting results, possibly because uniform groups of patients were not studied. patients who had multiple skin cancers (three or more) were studied to determine whether they had impaired cell-mediated immuni

Cell-mediated immune response in head an
Cell-mediated immune response in head and neck cancer patients
✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m

Impaired general cell-mediated immune fu
Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma
✍ S. H. Chan; T. S. Chew; E. H. Goh; M. J. Simons; K. Shanmugaratnam πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 493 KB πŸ‘ 1 views

## Abstract General cell‐mediated immune (CMI) functions in NPC patients were investigated by the __in vitro__ Mantoux and __in vitro__ lymphocyte response to PHA assays. Thirty‐eight (50%) of 76 untreated NPC patients were hyporesponsive in the Mantoux assay compared to 27 (25%) of 110 control pat